Ceritinib‐associated hyperglycemia in the Japanese Adverse Drug Event Report Database

Abstract Genetic rearrangements of anaplastic lymphoma kinase contribute to the pathogenesis of non‐small‐cell lung cancer; the anaplastic lymphoma kinase inhibitor, ceritinib, is widely used, as it is effective even in patients with non‐small‐cell lung cancer resistant to other anaplastic lymphoma...

Full description

Bibliographic Details
Main Authors: Haruka Fujita, Takaaki Murakami, Fumiaki Tomoike, Daisuke Yabe, Nobuya Inagaki
Format: Article
Language:English
Published: Wiley 2020-05-01
Series:Journal of Diabetes Investigation
Subjects:
Online Access:https://doi.org/10.1111/jdi.13168